The global peptide drug conjugates (PDCs) market is entering an era of transformative growth. Valued at USD 3,724.3 million in 2023, the market is expected to grow to USD 4,412.1 million in 2024 and soar to an impressive USD 15,535.6 million by 2031. This reflects a compound annual growth rate (CAGR) of 19.70 percent during the forecast period.
Driven by breakthroughs in targeted drug delivery...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Tiếng Việt